Ali Nihat Annakkaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ali Nihat Annakkaya has a total of 144 co-authors. Here are the top co-authors by number of shared publications:
- Ege Güleç Balbay
Duzce Universitesi
8 shared publications - Pınar Yıldız Gülhan
Department of Chest Diseases, Faculty of Medicine, Duzce University, Duzce, Turkey
8 shared publications - Peri Arbak
Duzce Universitesi
6 shared publications - Öner Balbay
Duzce Universitesi
6 shared publications - Oner Balbay
Department of Chest Diseases, Abant Izzet Baysal University, Duzce Medical School, Kenuralp 81620, Duzce, Turkey
3 shared publications - Cahit Bilgin
Sakarya University
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 32
Long-Term Outcomes of Mortality and CTEPH in Patients With Massive/Submassive Pulmonary Embolism Treated With Thrombolytics: Retro-Prospective Analysis
Aim: This study aimed to determine mortality and morbidity in patients receiving fibrinolytic therapy for massive/submassive PE and the clinical factors affecting these outcomes. Materials and Methods: All patients diagnosed with massive/submassive PE who received fibrinolytic therapy (alteplase) in our clinic between 2012 and 2024 were included in the study. Patients’ medical records were retrospectively reviewed using the automation system and patient files. Results: A total of 50 cases (31 women, 62%; 19 men, 38%) were included in the study. The mean age of the cases was 64±16 years (min: 21 – max: 93), and the median follow-up period was 1661 days (min: 1 – max: 4566 days). Half-dose fibrinolytic therapy was administered to 26% of cases, and full-dose therapy to 74%. The 2-day mortality rate was 10% (5/50), the 10-day mortality rate was26% (13/50), and the 30-day mortality rate was 28% (14/50). The median survival was found to be 2352 days (standard error: 304 days) for all cases who underwent reperfusion therapy. The 30-day mortality rate was significantly higher in patients receiving half-dose fibrinolytic therapy compared to those receiving full-dose therapy (53.8% vs. 18.9%, p=0.029). According to Cox regression analysis, malignancy was an independent risk factor negatively affecting survival, while obesity was a positive factor. CTEPH was detected in 28.5% (6/21) of the long-term followed cases. Conclusion: The effects of factors such as malignancy, obesity, and half-dose fibrinolytic therapy on mortality and morbidity in patients undergoing thrombolytic therapy with a diagnosis of massive/submassive PE should be investigated in more comprehensive studies.
- 1 January 2026
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 32
Open AccessLong-Term Outcomes of Mortality and CTEPH in Patients With Massive/Submassive Pulmonary Embolism Treated With Thrombolytics: Retro-Prospective Analysis
Aim: This study aimed to determine mortality and morbidity in patients receiving fibrinolytic therapy for massive/submassive PE and the clinical factors affecting these outcomes. Materials and Methods: All patients diagnosed with massive/submassive PE who received fibrinolytic therapy (alteplase) in our clinic between 2012 and 2024 were included in the study. Patients’ medical records were retrospectively reviewed using the automation system and patient files. Results: A total of 50 cases (31 women, 62%; 19 men, 38%) were included in the study. The mean age of the cases was 64±16 years (min: 21 – max: 93), and the median follow-up period was 1661 days (min: 1 – max: 4566 days). Half-dose fibrinolytic therapy was administered to 26% of cases, and full-dose therapy to 74%. The 2-day mortality rate was 10% (5/50), the 10-day mortality rate was26% (13/50), and the 30-day mortality rate was 28% (14/50). The median survival was found to be 2352 days (standard error: 304 days) for all cases who underwent reperfusion therapy. The 30-day mortality rate was significantly higher in patients receiving half-dose fibrinolytic therapy compared to those receiving full-dose therapy (53.8% vs. 18.9%, p=0.029). According to Cox regression analysis, malignancy was an independent risk factor negatively affecting survival, while obesity was a positive factor. CTEPH was detected in 28.5% (6/21) of the long-term followed cases. Conclusion: The effects of factors such as malignancy, obesity, and half-dose fibrinolytic therapy on mortality and morbidity in patients undergoing thrombolytic therapy with a diagnosis of massive/submassive PE should be investigated in more comprehensive studies.
- 11 July 2025
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 67 (11) , e771-e776
Assessment of Respiratory Health Among Volunteers Involved in Search and Rescue Operations During a Severe Earthquake
Objective: The aim of the study was to evaluate pulmonary functions in volunteers and assigned personnel involved in search and rescue or logistical activities during the early and late stages of a severe earthquake. Methods: A total of 287 individuals were administered within the first 45 days and at least after 3 months following their return. Results: Among those involved in search and rescue activities, the forced expiratory volume in the first second/forced vital capacity, absolute maximum mid flow rate, and % predicted maximum mid flow rate were significantly lower than those involved in other activities ( P < 001). The absolute carbon monoxide diffusion capacity (DLCO) and % predicted carbon monoxide diffusion capacity values measured at least 3 months after working in the earthquake zone were significantly lower than the initial measurements. Conclusions: Environmental conditions in earthquake zones may cause respiratory function impairments in search and rescue workers.
- 11 July 2025
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 67 (11) , e771-e776
Assessment of Respiratory Health Among Volunteers Involved in Search and Rescue Operations During a Severe Earthquake
Objective: The aim of the study was to evaluate pulmonary functions in volunteers and assigned personnel involved in search and rescue or logistical activities during the early and late stages of a severe earthquake. Methods: A total of 287 individuals were administered within the first 45 days and at least after 3 months following their return. Results: Among those involved in search and rescue activities, the forced expiratory volume in the first second/forced vital capacity, absolute maximum mid flow rate, and % predicted maximum mid flow rate were significantly lower than those involved in other activities ( P < 001). The absolute carbon monoxide diffusion capacity (DLCO) and % predicted carbon monoxide diffusion capacity values measured at least 3 months after working in the earthquake zone were significantly lower than the initial measurements. Conclusions: Environmental conditions in earthquake zones may cause respiratory function impairments in search and rescue workers.
- Open Access
- 18 December 2024
- Published by Elsevier in Sleep Medicine
- Vol. 126, 228-234
Sex differences in clinical and polysomnographic features of obstructive sleep apnea: The Turkish sleep apnea database (TURKAPNE) cohort
- 18 December 2024
- Published by Elsevier in Sleep Medicine
- Vol. 126, 228-234
Open AccessSex differences in clinical and polysomnographic features of obstructive sleep apnea: The Turkish sleep apnea database (TURKAPNE) cohort
- 29 April 2024
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (4) , 1597-1607
The Effect of Continuous Positive Airway Pressure (CPAP) Therapy on Serum Caspase-3 Level in Patients with Obstructive Sleep Apnea (OSA)
Introduction Intermittent hypoxemia has an important role in the physiopathogenesis of obstructive sleep apnea (OSA) complications. Increased apoptosis due to intermittent hypoxemia may be an important clinical entity in OSA. In this study, we aimed to evaluate caspase-3 enzyme level, which is an indirect marker of increased apoptosis in patients with OSA and to evaluate the effect of OSA treatment with continuous positive airway pressure on caspase-3 enzyme level. Materials and methods This study included 141 consecutive patients admitted to the sleep-disordered breathing laboratory within 6 months. Caspase-3 was measured in routine blood samples obtained on the morning of polysomnography (PSG) performed at night. The compliance of the patients to CPAP treatment was evaluated and caspase-3 levels were checked again after treatment. Results A total of 141 patients, 39 females (27,7%) and 102 males (72,3%) were included in the study. The mean age of the patients was 49 ± 12 years (min-17, max-77). According to PSG results, OSA was detected in 95.7% (135/141) of the cases. Mild OSA was 35 (24.8%), moderate OSA 39 (27.7%) and severe OSA 61 (43.3%) cases. Median caspase-3 enzyme levels were similar in men and women in the study group. There was no statistically significant difference in hemogram parameters and caspase-3 enzyme levels between the groups divided according to the presence and severity of OSA. It was determined that caspase-3 enzyme level did not change significantly after 3 months of CPAP treatment in OSA compared to pretreatment. Caspase-3 was found to have a negative correlation with both the percentage of daily use of CPAP therapy and the percentage of CPAP device use for more than 1 h per night. It was found that the control caspase-3 level decreased statistically significantly as the percentage of daily use of CPAP therapy increased (r = -0.397, p = 0.030). It was found that the control caspase-3 level decreased statistically significantly as the percentage of CPAP therapy use for more than 1 h per night increased (r = -0.411, p = 0.024). Conclusion The results of this study did not reveal a relationship between the severity of OSA and caspase-3 levels. However, blood caspase-3 levels decreased as treatment compliance increased, suggesting that CPAP treatment may correct increased apoptosis in OSA. There is a need for more comprehensive studies on this issue.
- 29 April 2024
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (4) , 1597-1607
The Effect of Continuous Positive Airway Pressure (CPAP) Therapy on Serum Caspase-3 Level in Patients with Obstructive Sleep Apnea (OSA)
Introduction Intermittent hypoxemia has an important role in the physiopathogenesis of obstructive sleep apnea (OSA) complications. Increased apoptosis due to intermittent hypoxemia may be an important clinical entity in OSA. In this study, we aimed to evaluate caspase-3 enzyme level, which is an indirect marker of increased apoptosis in patients with OSA and to evaluate the effect of OSA treatment with continuous positive airway pressure on caspase-3 enzyme level. Materials and methods This study included 141 consecutive patients admitted to the sleep-disordered breathing laboratory within 6 months. Caspase-3 was measured in routine blood samples obtained on the morning of polysomnography (PSG) performed at night. The compliance of the patients to CPAP treatment was evaluated and caspase-3 levels were checked again after treatment. Results A total of 141 patients, 39 females (27,7%) and 102 males (72,3%) were included in the study. The mean age of the patients was 49 ± 12 years (min-17, max-77). According to PSG results, OSA was detected in 95.7% (135/141) of the cases. Mild OSA was 35 (24.8%), moderate OSA 39 (27.7%) and severe OSA 61 (43.3%) cases. Median caspase-3 enzyme levels were similar in men and women in the study group. There was no statistically significant difference in hemogram parameters and caspase-3 enzyme levels between the groups divided according to the presence and severity of OSA. It was determined that caspase-3 enzyme level did not change significantly after 3 months of CPAP treatment in OSA compared to pretreatment. Caspase-3 was found to have a negative correlation with both the percentage of daily use of CPAP therapy and the percentage of CPAP device use for more than 1 h per night. It was found that the control caspase-3 level decreased statistically significantly as the percentage of daily use of CPAP therapy increased (r = -0.397, p = 0.030). It was found that the control caspase-3 level decreased statistically significantly as the percentage of CPAP therapy use for more than 1 h per night increased (r = -0.411, p = 0.024). Conclusion The results of this study did not reveal a relationship between the severity of OSA and caspase-3 levels. However, blood caspase-3 levels decreased as treatment compliance increased, suggesting that CPAP treatment may correct increased apoptosis in OSA. There is a need for more comprehensive studies on this issue.
- 28 December 2023
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 16 (1) , 32-41
Obstrüktif Uyku Apnede (OUA) Ortalama Trombosit Hacmi (OTH) ve OUA'da Sürekli Pozitif Hava Yolu Basıncı (CPAP) Tedavisinin OTH Üzerine Etkisi
Aims: In this study, our objective was to evaluate mean platelet volume (MPV), an indirect marker of platelet activation, in patients with obstructive sleep apnea (OSA), and assess the effect of OSA treatment with continuous positive airway pressure (CPAP) on MPV Methods: In this study, records of consecutive patients who underwent polysomnographic evaluation for OSA symptoms in the Sleep Disorders Laboratory during a one-year period were reviewed retrospectively. Patients who had both complete blood count and MPV measurements were included in the study. Results: A total of 158 patients, including 51 females (32.3%) and 107 males (67.7%), were included in the study. The mean age of the patients was 51±13 (min-18, max-82) years. OSA was detected in 74.1% (117/158) of the patients. It was determined that as the severity of OSA increased, hemoglobin and hematocrit values increased significantly. There was no significant difference in platelet count according to the presence and severity of OSA. The MPV was significantly lower in severe OSA cases compared to those without OSA and mild OSA cases. A negative correlation was observed between MPV and the apnea-hypopnea index, desaturation index, and the amount of oxygen saturation below 90% during sleep. There was no significant difference in median erythrocyte and thrombocyte counts, hematocrit percentage and hemoglobin values before and after treatment in OSA patients who used CPAP therapy. However, a significant decrease in MPV was observed after OSA treatment compared to pre-treatment. (p=0.021). Conclusions: The results of the study do not support an increase in MPV and hence platelet activation in severe OSA patients compared with those without OSA. However, the results suggest that one month of CPAP treatment reduces MPV and thus platelet activation in severe OSA patients. Further controlled, prospective studies including treatment outcomes are needed on this subject.
- 28 December 2023
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 16 (1) , 32-41
Obstrüktif Uyku Apnede (OUA) Ortalama Trombosit Hacmi (OTH) ve OUA'da Sürekli Pozitif Hava Yolu Basıncı (CPAP) Tedavisinin OTH Üzerine Etkisi
Aims: In this study, our objective was to evaluate mean platelet volume (MPV), an indirect marker of platelet activation, in patients with obstructive sleep apnea (OSA), and assess the effect of OSA treatment with continuous positive airway pressure (CPAP) on MPV Methods: In this study, records of consecutive patients who underwent polysomnographic evaluation for OSA symptoms in the Sleep Disorders Laboratory during a one-year period were reviewed retrospectively. Patients who had both complete blood count and MPV measurements were included in the study. Results: A total of 158 patients, including 51 females (32.3%) and 107 males (67.7%), were included in the study. The mean age of the patients was 51±13 (min-18, max-82) years. OSA was detected in 74.1% (117/158) of the patients. It was determined that as the severity of OSA increased, hemoglobin and hematocrit values increased significantly. There was no significant difference in platelet count according to the presence and severity of OSA. The MPV was significantly lower in severe OSA cases compared to those without OSA and mild OSA cases. A negative correlation was observed between MPV and the apnea-hypopnea index, desaturation index, and the amount of oxygen saturation below 90% during sleep. There was no significant difference in median erythrocyte and thrombocyte counts, hematocrit percentage and hemoglobin values before and after treatment in OSA patients who used CPAP therapy. However, a significant decrease in MPV was observed after OSA treatment compared to pre-treatment. (p=0.021). Conclusions: The results of the study do not support an increase in MPV and hence platelet activation in severe OSA patients compared with those without OSA. However, the results suggest that one month of CPAP treatment reduces MPV and thus platelet activation in severe OSA patients. Further controlled, prospective studies including treatment outcomes are needed on this subject.
- 20 October 2023
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 15 (3) , 331-339
The Prevalence of Obstructive Sleep Apnea in Bariatric Surgery Patients
Objective: Obesity is one of the most important risk factors and also consequences of obstructive sleep apnea (OSA). Weight loss and positive airway pressure therapy are the main approaches in the treatment of OSA. In this study, it was aimed to evaluate the prevalence of OSA in obesity patients scheduled for bariatric surgery. Methods: In the University Hospital Obesity Center, 141 consecutive patients who were candidates for bariatric surgery in 2015 were clinically evaluated preoperatively for sleep-related respiratory disorders. Preoperative polysomnographic examination was recommended to all cases. Results: Of 141 bariatric surgery candidates with a mean age of 37±10 years, and 103 (73%) were female. The mean body mass index of the cases was 46.9±6.4 kg/m2. Among the major symptoms of OSA, snoring was present in 119 (84.4%), daytime sleepiness in 63 (44.7%) and witnessed apnea in 49 (34.8%) patients. OSA was detected because AHI>5/hour was found in 75.7% (84/111) of the patients who accepted the polysomnographic evaluation. 24.3% (27/111) of the cases who underwent polysomnography had non OSA, 29.7% (33/111) mild OSA, 17.1% (19/111) moderate OSA, and 28.8% (32 /111), severe OSA was detected. AHI was positively correlated with age (p=0.003), neck and waist diameter (p
- 20 October 2023
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 15 (3) , 331-339
The Prevalence of Obstructive Sleep Apnea in Bariatric Surgery Patients
Objective: Obesity is one of the most important risk factors and also consequences of obstructive sleep apnea (OSA). Weight loss and positive airway pressure therapy are the main approaches in the treatment of OSA. In this study, it was aimed to evaluate the prevalence of OSA in obesity patients scheduled for bariatric surgery. Methods: In the University Hospital Obesity Center, 141 consecutive patients who were candidates for bariatric surgery in 2015 were clinically evaluated preoperatively for sleep-related respiratory disorders. Preoperative polysomnographic examination was recommended to all cases. Results: Of 141 bariatric surgery candidates with a mean age of 37±10 years, and 103 (73%) were female. The mean body mass index of the cases was 46.9±6.4 kg/m2. Among the major symptoms of OSA, snoring was present in 119 (84.4%), daytime sleepiness in 63 (44.7%) and witnessed apnea in 49 (34.8%) patients. OSA was detected because AHI>5/hour was found in 75.7% (84/111) of the patients who accepted the polysomnographic evaluation. 24.3% (27/111) of the cases who underwent polysomnography had non OSA, 29.7% (33/111) mild OSA, 17.1% (19/111) moderate OSA, and 28.8% (32 /111), severe OSA was detected. AHI was positively correlated with age (p=0.003), neck and waist diameter (p
- 11 February 2023
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 65 (5) , e279-e282
The Relationship Between Respiratory Complaints and Urine Aluminum Levels in Aluminum Factory Workers
Objective: This prospective case-control study aimed to investigate the forms and conditions of respiratory effects in workers working in an Aluminum Profile Factory. Methods: All male (42 person, mean age: 32.2 ± 6.9) workers working in an Aluminum Profile Factory were compared with 33 controls. Results: The urinary aluminum levels of the workers were significantly higher than the control group. Complaints of cough, sputum, shortness of breath and wheezing were statistically significantly higher than the control group. In aluminum workers, those with dyspnea had a significantly higher urinary Al level than those without dyspnea. Conclusions: It is thought that primary and secondary prevention are both important in the workplaces with aluminum exposure. Urinary aluminum level monitoring could be key to protecting the respiratory health of the workers.
- 11 February 2023
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 65 (5) , e279-e282
The Relationship Between Respiratory Complaints and Urine Aluminum Levels in Aluminum Factory Workers
Objective: This prospective case-control study aimed to investigate the forms and conditions of respiratory effects in workers working in an Aluminum Profile Factory. Methods: All male (42 person, mean age: 32.2 ± 6.9) workers working in an Aluminum Profile Factory were compared with 33 controls. Results: The urinary aluminum levels of the workers were significantly higher than the control group. Complaints of cough, sputum, shortness of breath and wheezing were statistically significantly higher than the control group. In aluminum workers, those with dyspnea had a significantly higher urinary Al level than those without dyspnea. Conclusions: It is thought that primary and secondary prevention are both important in the workplaces with aluminum exposure. Urinary aluminum level monitoring could be key to protecting the respiratory health of the workers.
- Open Access
- 20 January 2023
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 13 (1) , 93-98
COVID-19 Olası/Kesin Tanılı Hastalarda Serbest Radikal Ve Antioksidan Enzim Düzeylerinin Değerlendirilmesi
Aim: Although coronavirus disease 2019 (COVID-19) is a complex disease threatening global public health and leading to a pandemic, the contributions of the pro-oxidant/oxidant imbalance involved in the pathogenesis of the disease have not been adequately studied. Therefore, the aim of this study is to evaluate the effects of smoking on oxidative stress and antioxidant defense system biomarkers in COVID-19 patients. Material and Methods: Participants were divided into 4 groups in the study: (Control group) 45 healthy individuals without a diagnosis of COVID-19 and not smoking, (Group 2) 45 individuals without a diagnosis of COVID-19 and smoking, (Group 3) 45 patients with a diagnosis of COVID-19 and not smoking, (Group 4) 45 patients with a diagnosis of COVID-19 and smoking 45 patients. D-dimer, nitric oxide (NO), glutathione reductase (GR), superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), total antioxidant levels (TAS) and total oxidant levels (TOS) in the serum of the participants were analyzed using commercial kits according to the ELISA method. Results: There is a significant increase in D-dimer levels in people diagnosed with COVID-19 (p<0.001). TAS, CAT, SOD and GR levels in Group II, Group III and Group IV showed a statistical decrease when compared to the control group. Compared to the control group, there was a significant increase in TOS and MDA levels, especially in Group IV (p<0.001). In addition, NO levels in Group II, Group III and Group IV were significantly increased compared to the control group (p<0.001). Conclusion: Our data show that smoking increases oxidative and nitrosative damage in COVID-19. Amaç: Koronavirüs hastalığı 2019 (COVID-19), küresel halk sağlığını tehdit eden ve bir pandemiye yol açan karmaşık bir hastalık olmasına rağmen, hastalığın patogenezinde yer alan pro-oksidan/oksidan dengesizliğinin katkıları yeterince araştırılmamıştır. Bu nedenle, bu çalışmanın amacı, COVID-19 hastalarında sigara kullanımının oksidatif stres ve antioksidan savunma sistemi biyobelirteçleri üzerindeki etkilerini değerlendirmektir. Gereç ve Yöntemler: Çalışmaya katılan kişiler 4 gruba ayrıldı: (Kontrol grubu) COVID-19 tanısı olmayan ve sigara kullanmayan 45 sağlıklı birey, (Grup 2) COVID-19 tanısı olmayan ve sigara kullanan 45 birey, (Grup 3) COVID-19 tanılı ve sigara kullanmayan 45 hasta, (Grup 4) COVID-19 tanılı ve sigara kullanan 45 hasta. Katılımcıların serumlarındaki D-dimer, nitrik oksit (NO), glutatyon redüktaz (GR), süperoksit dismutaz (SOD), katalaz (CAT), malondialdehid (MDA), total antioksidan seviyeleri (TAS) ve total oksidan seviyeleri (TOS) seviyelerini ticari kitler kullanarak ELİSA yöntemine göre analiz edildi. Bulgular: COVID-19 tanısı alan kişilerdeki D-dimer seviyelerinde anlamlı bir artış söz konusudur (p<0,001). Grup II, Grup III ve Grup IV’deki TAS, CAT, SOD ve GR seviyeleri kontrol grubu ile karşılaştırıldığında istatiksel olarak bir düşüş göstermiştir. Kontrol grubu ile karşılaştırıldığında özellikle de Grup IV’deki TOS ve MDA seviyelerinde ciddi artış olmuştur (p<0,001). Ek olarak, Grup II, Grup III ve Grup IV’deki NO seviyeleri kontrol grubuna göre anlamlı bir şekilde artmıştır (p<0,001). Sonuç: Verilerimiz, sigara kullanımının COVID-19'daki oksidatif ve nitrozatif hasarı arttırdığı göstermektedir.
- 20 January 2023
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 13 (1) , 93-98
Open AccessCOVID-19 Olası/Kesin Tanılı Hastalarda Serbest Radikal Ve Antioksidan Enzim Düzeylerinin Değerlendirilmesi
Aim: Although coronavirus disease 2019 (COVID-19) is a complex disease threatening global public health and leading to a pandemic, the contributions of the pro-oxidant/oxidant imbalance involved in the pathogenesis of the disease have not been adequately studied. Therefore, the aim of this study is to evaluate the effects of smoking on oxidative stress and antioxidant defense system biomarkers in COVID-19 patients. Material and Methods: Participants were divided into 4 groups in the study: (Control group) 45 healthy individuals without a diagnosis of COVID-19 and not smoking, (Group 2) 45 individuals without a diagnosis of COVID-19 and smoking, (Group 3) 45 patients with a diagnosis of COVID-19 and not smoking, (Group 4) 45 patients with a diagnosis of COVID-19 and smoking 45 patients. D-dimer, nitric oxide (NO), glutathione reductase (GR), superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), total antioxidant levels (TAS) and total oxidant levels (TOS) in the serum of the participants were analyzed using commercial kits according to the ELISA method. Results: There is a significant increase in D-dimer levels in people diagnosed with COVID-19 (p<0.001). TAS, CAT, SOD and GR levels in Group II, Group III and Group IV showed a statistical decrease when compared to the control group. Compared to the control group, there was a significant increase in TOS and MDA levels, especially in Group IV (p<0.001). In addition, NO levels in Group II, Group III and Group IV were significantly increased compared to the control group (p<0.001). Conclusion: Our data show that smoking increases oxidative and nitrosative damage in COVID-19. Amaç: Koronavirüs hastalığı 2019 (COVID-19), küresel halk sağlığını tehdit eden ve bir pandemiye yol açan karmaşık bir hastalık olmasına rağmen, hastalığın patogenezinde yer alan pro-oksidan/oksidan dengesizliğinin katkıları yeterince araştırılmamıştır. Bu nedenle, bu çalışmanın amacı, COVID-19 hastalarında sigara kullanımının oksidatif stres ve antioksidan savunma sistemi biyobelirteçleri üzerindeki etkilerini değerlendirmektir. Gereç ve Yöntemler: Çalışmaya katılan kişiler 4 gruba ayrıldı: (Kontrol grubu) COVID-19 tanısı olmayan ve sigara kullanmayan 45 sağlıklı birey, (Grup 2) COVID-19 tanısı olmayan ve sigara kullanan 45 birey, (Grup 3) COVID-19 tanılı ve sigara kullanmayan 45 hasta, (Grup 4) COVID-19 tanılı ve sigara kullanan 45 hasta. Katılımcıların serumlarındaki D-dimer, nitrik oksit (NO), glutatyon redüktaz (GR), süperoksit dismutaz (SOD), katalaz (CAT), malondialdehid (MDA), total antioksidan seviyeleri (TAS) ve total oksidan seviyeleri (TOS) seviyelerini ticari kitler kullanarak ELİSA yöntemine göre analiz edildi. Bulgular: COVID-19 tanısı alan kişilerdeki D-dimer seviyelerinde anlamlı bir artış söz konusudur (p<0,001). Grup II, Grup III ve Grup IV’deki TAS, CAT, SOD ve GR seviyeleri kontrol grubu ile karşılaştırıldığında istatiksel olarak bir düşüş göstermiştir. Kontrol grubu ile karşılaştırıldığında özellikle de Grup IV’deki TOS ve MDA seviyelerinde ciddi artış olmuştur (p<0,001). Ek olarak, Grup II, Grup III ve Grup IV’deki NO seviyeleri kontrol grubuna göre anlamlı bir şekilde artmıştır (p<0,001). Sonuç: Verilerimiz, sigara kullanımının COVID-19'daki oksidatif ve nitrozatif hasarı arttırdığı göstermektedir.
- 20 October 2022
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 14 (3) , 497-502
The Clinical Correlations of Fatigue in Patients with Sarcoidosis
Objective: Fatigue is considered a frequent and characteristic feature of sarcoidosis. This study was designed to determine the prevalence of fatigue in patients with sarcoidosis and to determine its potential clinical correlations in relation to symptom severity. Methods: A total of 56 sarcoidosis patients were included. Data on patient demographics, anthropometrics, disease characteristics, pulmonary function tests, 6-min walking distance (6MWD), blood biochemistry and hemogram findings were retrieved from hospital records. Psychometric instruments involved the fatigue assessment scale (FAS), Beck Depression Inventory (BDI) and Short Form-36 (SF-36) for health-related QOL (HRQOL). Results: Mean±SD patient age was 50.9±11.9 years. Of 56 patients, 44 were females and 12 were males. When compared to FAS score
- 20 October 2022
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 14 (3) , 497-502
The Clinical Correlations of Fatigue in Patients with Sarcoidosis
Objective: Fatigue is considered a frequent and characteristic feature of sarcoidosis. This study was designed to determine the prevalence of fatigue in patients with sarcoidosis and to determine its potential clinical correlations in relation to symptom severity. Methods: A total of 56 sarcoidosis patients were included. Data on patient demographics, anthropometrics, disease characteristics, pulmonary function tests, 6-min walking distance (6MWD), blood biochemistry and hemogram findings were retrieved from hospital records. Psychometric instruments involved the fatigue assessment scale (FAS), Beck Depression Inventory (BDI) and Short Form-36 (SF-36) for health-related QOL (HRQOL). Results: Mean±SD patient age was 50.9±11.9 years. Of 56 patients, 44 were females and 12 were males. When compared to FAS score
- 20 July 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 50 (10) , 1125-1132
An assessment of post-COVID-19 infection pulmonary functions in healthcare professionals
- 20 July 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 50 (10) , 1125-1132
An assessment of post-COVID-19 infection pulmonary functions in healthcare professionals